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factors that recruit decapping enzymes is
one possibility; another is that slower ri-
bosomal elongation could result in a lower
rate of initiation from recycled ribosomes
reinitiating on circularized transcripts.
Mechanisms aside, these studies indi-
cate that both the onset and the physical
process of 50/ 30 decay, like other path-
ways of mRNA surveillance that occur on
the ribosome (Shoemaker and Green,
2012), are coupled to translation.
In these genome-scale studies, we
continue to see translation through a
high-throughput glass, darkly. Debates
rage about whether ribosomes pause at
some codons, or amino acids, and not
others, with seemingly minor differences
in growth conditions, sample preparation,
and statistical methods yielding incom-
patible results. Distinguishing biolog-
ical phenomena from aberrations in the
experimental glass remains challenging.
What solid ground can the translation field
stand on? Very strong signals pop out
consistently, such as ribosome pausing
at the SecM sequence in bacteria or
codon-specific pausing during amino
acid starvation (Subramaniam et al.,
2014). Weaker signals may be detectable
if amplified, such as by prolonging1248 Cell 161, June 4, 2015 ª2015 Elsevier Inpausing by deletion of release factors
(Guydosh and Green, 2014) or addition
of artificial amino acid analogs. Details of
RNA preparation, including inhibitors, 50
chemistry, nuclease digestion conditions,
and fragment length, may create or defeat
artifacts and determine detectable phe-
nomena. Which protocol details can be
safely ignored? We do not yet know.
Substantial unexplainedvariation in read
densities generated by high-throughput
sequencing makes single-gene profiles
difficult to interpret, and any individual
peak or trough might be artifactual.
Although statistical methods such as
‘‘metagene analysis’’ can reveal signals
by aggregating across the transcriptome,
any analysis pipeline might mislead and
must be validated. It is unclear whether
such methods are quantitative. Does a
2-fold increase in some model output
correspond to a 2-fold decrease in ribo-
some elongation? In particular, failing to
detect a signal with a particular high-
throughput strategy (e.g., codon-specific
pausing in ribosome profiling) does not
mean the signal is absent. The signal may
be detectable by alternative assays or
even by alternative analyses of the same
data. The arrival of 5PSeq providesc.valuable checks on the results of other
high-throughput methods.
As the serendipitous discovery of sensi-
tive last-ribosome dynamics exemplifies,
the accumulation of new and independent
methods continues to sharpen our global
picture of translation in ways that will
inspire future studies—and confidence.
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Epigenetic reprogramming in the germline resets genomic potential and erases epigeneticmemory.
Three studies by Gkountela et al., Guo et al., and Tang et al. analyze the transcriptional and epige-
netic landscape of humanprimordial germcells, revealing a unique transcriptional network and pro-
gressive and conserved global erasure of DNA methylation.Germ cells uniquely transmit the genetic
information from one generation to the
next and give rise to the totipotent zygote
upon fertilization. While the geneticmaterial of the parents is maintained, the
epigenome undergoes extensive reprog-
ramming in primordial germ cells (PGCs),
the precursors of sperm and oocytes.Despite this pivotal role of PGCs for
development and fertility, their specifica-
tion and epigenetic reprogramming in
the human embryo remain relatively
uncharacterized, and much of our knowl-
edge is based on studies in mice in which
reprogramming was first discovered
(Hackett et al., 2013; Kobayashi et al.,
2013; Seisenberger et al., 2012). Three
papers published in this issue of Cell
(Gkountela et al., 2015; Guo et al., 2015;
Tang et al., 2015) chart the transcriptional
and epigenetic changes during human
PGC development, revealing the remark-
able conservation of global erasure of
DNA methylation and the distinct gene
regulatory network orchestrating epige-
netic remodeling and gametogenesis.
Human germ cell development (Fig-
ure 1A) begins with the specification of
PGCs, which is expected to happen at
the onset of gastrulation (developmental
week 2) in the posterior epiblast of early
postimplantation embryos. During gesta-
tion (weeks 3–5), the definitive PGCs
migrate from the yolk sac wall through
the hindgut to the developing gonads,
where they then undergo sex-specific
differentiation after week 9. Whereas the
male germ cells enter mitotic quiescence
synchronously and undergo meiosis after
puberty, female human germ cells enter
meiosis asynchronously over an extended
time period (Gkountela et al., 2013).
Gkountela et al. (2015),Guoet al. (2015),
and Tang et al. (2015) isolate PGCs from
4- to 19-week-old human embryos by
fluorescence-activated cell sorting for
the surface markers cKIT and/or TNAP
and perform RNA sequencing (RNA-seq)
(for the transcriptome) andwhole-genome
bisulfite sequencing (for the methylome).
These analyses represent the first com-
prehensive datasets of early human germ
cells in vivo and reveal that DNA methyl-
ation is progressively erased genome
wide in PGCs to the lowest levels of CpG
methylation observed in the human
genome to date.
Global methylation levels in early PGCs
(weeks 4–7) are already low compared to
somatic cells, indicating that the first
wave of global DNA demethylation occurs
before 4–7 weeks of development.
Furthermore, low methylation levels are
maintained in female and male PGCs until
embryonic week 16 or 19, respectively,
implying that global re-methylation oc-
curs later.
A comparison of the methylomes from
human and mouse germ cells reveals
remarkable parallels, with overall similarDNA demethylation dynamics in human
PGCs between developmental week 5 to
19 and those of mice between embryonic
day (E) 10.5 to 13.5. This suggests that
epigenetic reprogramming of the germline
is a fundamental process in mammals,
which seems highly conserved. Nonethe-
less, although all three studies report
similar dynamics in the changes of spe-
cific genomic features, the exact methyl-
ation levels and timelines vary between
each other. These differences might be
purely a consequence of the difficulties
in isolating in vivo human germ cells and
slightly different sample preparation but
could also point to real biological differ-
ences. In contrast to inbred mice, human
samples will all be genetically dissimilar,
which could perhaps result in slightly
different levels and timelines of epigenetic
resetting in the germline.
The global demethylation observed in
human PGCs leads to a dramatic loss of
almost all DNA methylation at CpG
islands, transcription start sites, gene
bodies, and surrounding intergenic re-
gions, compared to human methylomes
from the inner cell mass, somatic cells,
or sperm. Nonetheless, in PGCs, gene
bodies remain slightly higher methylated
than the neighboring intergenic regions.
As in the mouse, the loss of CpG methyl-
ation does not correlate with changes in
gene expression in the human germline,
suggesting that erasure of epigenetic
memory is a key purpose of demethyla-
tion. When looking at the major types of
transposable elements, which make up
about half of the human genome, the au-
thors find that these follow the trend for
the genome average. However, a signifi-
cant fraction of specific subfamilies
show persistent methylation, and in
particular, the evolutionarily youngest
and currently active retrotransposons
aremore resistant to global demethylation
(again resembling the mouse). As global
demethylation of transposable elements
does not lead to significant transcriptional
activation, other repressive mechanisms
must be in place. Whereas mouse germ-
line cells show a persistent enrichment
of the repressive chromatin mark
H3K27me3 and global loss of H3K9me2
(Seki et al., 2005), human PGCs are
depleted for H3K9me2 and H3K27me3
(Figure 1B). Similar to the mouse, a clear
punctuated pattern of the stable silencingCell 1markH3K9me3 can be detected in human
PGCs at all stages of development, sug-
gesting that H3K9me3 may be the key
factor repressing the constitutive hetero-
chromatin in human PGCs.
A hallmark of epigenetic resetting in the
germline is imprint erasure (Hackett et al.,
2013; Kobayashi et al., 2013; Seisen-
berger et al., 2012). In contrast to the
mouse, hypomethylation of imprints in hu-
mans seems to occur before PGCs colo-
nize the genital ridge and is maintained
until at least 19 weeks of development
(Figure 1B). In mouse PGCs, the inactive
X chromosome is reactivated between
E8.5 and E12.5, and Tang et al. (2015)
and Guo et al. (2015) report X reactivation
already in human PGCs prior to 4 weeks
of development (Figure 1B). Notably,
Gkountela et al. (2015) detect expression
of XIST noncoding RNA in male and fe-
male germline cells at all stages, suggest-
ing that XIST may be non-silencing in the
human germline.
Tanget al. (2015) further examine the re-
gions that (partially) escape global deme-
thylation and are repeat poor, potentially
representing hotspots of transgenera-
tional epigenetic inheritance. Among
them, they identify several genes with
characteristic trait and disease associa-
tions, such as ‘‘obesity-related traits,’’
‘‘schizophrenia,’’ and ‘‘multiple sclerosis.’’
Mechanistically, global loss of DNA
methylation in mouse PGCs is a conse-
quence of suppression of maintenance
and de novo methylation by PRDM14
and activation of active DNA demethyla-
tion pathways. Surprisingly, PRDM14 is
dispensable for human PGCdevelopment
(Sugawa et al., 2015) and only expressed
at very low levels in the human germline.
Perhaps consequently, mRNAs of de
novo DNMTs, DNMT1, and UHRF1 are
present, but protein levels of DNMT3A
and UHRF1 are not detectable by immu-
nofluorescence (IF) in human PGCs, sug-
gesting an alternative mechanism that
suppresses maintenance and de novo
methylation. TET1 and TET2 are also en-
riched in human PGCs, and significant
levels of 5hmC are detected by IF in early
human PGCs. Guo et al. (2015) also
perform TAB-seq onmale 10week human
PGCs and identify global levels of 1.9%
5hmC in the genome.
Furthermore, the transcriptome of hu-
man mitotic PGCs before 10 or 11 weeks61, June 4, 2015 ª2015 Elsevier Inc. 1249
Figure 1. Epigenetic Reprogramming in Human Primordial Germ Cells
(A) After fertilization, the paternal (blue) and maternal (red) genomes undergo global demethylation, resetting the human epigenome for naive pluripotency at the
blastocyst stage. Following a yet-uncharacterized phase of de novomethylation in the epiblast, human PGCs are specified in the posterior epiblast (week 2), from
where they migrate through the hindgut to the developing genital ridges. During this migratory phase (weeks 3–5), human PGCs must undergo a first wave of
global DNA demethylation, including significant loss of methylation at imprint control regions. The methylomes and transcriptomes from human PGCs between
5.5 and 19weeks of age have now been analyzed. During this phase, DNAmethylation is further erased genomewide, restoring germline potency, whereas only a
small number of evolutionarily young transposable elements and single copy genes are not completely demethylated and could be potential sites of trans-
generational epigenetic inheritance.
(B) The chart summarizes the main transcriptional and epigenetic characteristics of human germ cell development and also highlights key differences between
human and mouse PGCs (marked in red).
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is, in general, stable without prominent
differences between male and female
PGCs and similar to human ICM cells
but distinct from older PGCs. This sug-
gests that, after 10 or 11 weeks of age,
the germline cells transition to another
state, and single-cell RNA-seq analysis
of individual PGCs by Guo et al. (2015)
also show strong heterogeneity in
17 week female PGCs, supporting the
observation that female germ cells enter
meiosis asynchronously in humans. Late
female PGCs also start to express
markers of meiosis (e.g., SYPC1 and
SYPC3), whereas mitotically arrested
late male PGCs already express a signifi-
cant number of genes related to sper-
matogenesis and sexual reproduction.
The comparison of human and mouse
PGCs show that PGCs share a core tran-
scriptome of key germ cell genes (e.g.,
BLIMP1, TFAP2C, DAZL, and DPP3A)
and pluripotency genes (e.g., OCT4,
NANOG, and LIN28A) with some notable
differences, including lack of ESRRB,
SOX2, or SOX3 expression in human
PGCs and strong expression of naive plu-
ripotency genes KLF4 and TFCP2L. While
the PGC-specific modules also included
SOX17, which has recently been reportedto be a critical specifier for human PGCs
(Irie et al., 2015), Guo et al. (2015) report
that SOX15 is expressed more homoge-
nously and at a much higher level specif-
ically in early PGCs, suggesting a possible
key functional role for human PGC devel-
opment (Figure 1B).
In conclusion, these studies provide
detailed maps of the transcriptional and
epigenetic events that are fundamental
for resetting genomic potential, erasing
epigenetic memory, and establishing the
human germline. This knowledge will
help to better understand the epigenetic
regulation of human development, and
future work might identify potential bio-
logical differences underlying the discrep-
ancies in overall methylation levels and
timelines between the three studies.
Whether such differences suggest that
the extent of reprogramming and poten-
tially transgenerational epigenetic inheri-
tance could be regulated in mammals is
an intriguing question for future work.REFERENCES
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